|
Petroleum distillates (naphtha) | CAS 8002-05-9 | ||
|
RTECS SE7449000 | ||
Synonyms & Trade Names Aliphatic petroleum naphtha, Petroleum naphtha, Rubber solvent |
DOT ID & Guide 1255 128 |
Exposure Limits |
NIOSH REL: TWA 350 mg/m3 C 1800 mg/m3 [15-minute] | ||
OSHA PEL�: TWA 500 ppm (2000 mg/m3) | |||
IDLH 1100 ppm [10%LEL] | Conversion 1 ppm = 4.05 mg/m3 |
Physical Description Colorless liquid with a gasoline- or kerosene-like odor. [Note: A mixture of paraffins (C5 to C13) that may contain a small amount of aromatic hydrocarbons.] |
|||
MW: 99 (approx) |
BP: 86-460°F |
FRZ: -99°F |
Sol: Insoluble |
VP: 40 mmHg (approx) |
IP: ? |
|
Sp.Gr: 0.63-0.66 |
Fl.P: -40 to -86°F |
UEL: 5.9% |
LEL: 1.1% |
|
Flammable Liquid | |||
Incompatibilities & Reactivities Strong oxidizers |
Measurement Methods NIOSH 1550 |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations
NIOSH Up to 850 ppm: (APF = 10) Any supplied-air respirator Up to 1100 ppm: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode*/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, nose, throat; dizziness, drowsiness, headache, nausea; dry cracked skin; chemical pneumonitis (aspiration liquid) | |
Target Organs
Eyes, skin, respiratory system, central nervous system |
See also: INTRODUCTION |